IGLOO
LIVE

Serial Number

79288186

Owner

Experiment X Ltd

Filing Date

Apr 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IGLOO Trademark

Serial Number: 79288186 • Registration: 6398822

IGLOO is a trademark filed by Experiment X Ltd on April 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Experiment X Ltd (2 trademarks)

4th Floor, Beaumont House,

Entity Type: 99

Dx365 UG

Hedwig-Porschütz-Str. 14

Entity Type: 99

Trademark Details

Filing Date

April 9, 2020

Registration Date

June 29, 2021

Published for Opposition

April 13, 2021

Goods & Services

Custom manufacture of medical devices for others; custom manufacture of medical devices for others, namely devices for medical diagnostics, health tracking, telemedicine, telehealth, devices for screening testing, analyzing and monitoring of biological material, immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices

Diagnostic reagents for medical use; diagnostic reagents for medical use, namely for screening testing, analyzing and monitoring of biological material; diagnostic reagents for medical use, namely for immunoassays, lateral flow immunoassays, multiplex immunoassays, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices, polymerase chain reaction devices; diagnostic substances for medical use for sale in kit form; diagnostic scanning agents for in-vitro medical use; diagnostic testing reagents for testing of body fluids for medical use; diagnostic preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes

Medical services; medical services, namely services for diagnostics, health tracking, telemedicine, telehealth; medical services, namely services for screening testing, analyzing and monitoring of biological material

Medical apparatus, instruments, equipment and devices, namely devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely point-of-care devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely, immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; medical testing kits, namely medical testing kits including immunoassays, lateral flow immunoassays, multiplex immunoassays, and microfluidics; diagnostic apparatus and instruments for screening testing, analyzing and monitoring of biological material

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Apr 5, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 21, 2021 FICS
NEW REPRESENTATIVE AT IB RECEIVED
Oct 21, 2021 NREP
FINAL DISPOSITION PROCESSED
Oct 20, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 29, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 29, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 12, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 25, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 5, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Jun 30, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 25, 2020 REPR